Ads
related to: sanofi- Get Fabry Support
Discover Fabry Disease Resources
to Help You Manage the Disease
- Keep Up To Date
Stay Informed and Receive Updates
About Fabry Disease
- Fabry's Hidden Impact
Extended Info
on the Hidden Impact of Fabry
- Let's Rethink Fabry
Expanded Library
of Fabry Disease Videos & Webinars
- Get Fabry Support
Search results
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
Reuters via Yahoo News· 54 minutes agoSanofi last year said it would seek U.S. approval for its anti-inflammatory drug Dupixent for COPD...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 53 minutes agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target action date of ...
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via AOL· 2 days agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
3 Key Euronext Paris Dividend Stocks Offering Up To 7.2% Yield
Simply Wall St. via Yahoo Finance· 22 minutes agoAmid a backdrop of fluctuating European markets with France's CAC 40 Index recently experiencing a...
Rebuilding Trust In Healthcare: A Critical Path For Disabled People
Forbes· 1 day agoIn doing so I may have been inadvertently contributing to the causes of disability discrimination....
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 6 days agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
WTRF Wheeling· 6 days agoInhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company's stockholders approved the sale to Sanofi
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Ad
related to: sanofi